We are live on ! Find out more
AUXL

AUXILIUM PHARAMCEUTICALS INC
AUXL

Delisted

AUXL was delisted on the 29th of January, 2015.

Back to rankings

152 hedge funds and large institutions have $880M invested in AUXILIUM PHARAMCEUTICALS INC in 2013 Q2 according to their latest regulatory filings, with 152 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more call options, than puts

Call options by funds: $25.8M | Put options by funds: $21.6M

Holders
152
Holders Change
+152
Holders Change %
–
% of All Funds
4.96%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
152
Increased
–
Reduced
–
Closed
–
Calls
$25.8M
Puts
$21.6M
Net Calls
+$4.2M
Net Calls Change
+$4.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$80.7M +$77.5M +4,850,644 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$49.1M +$47.2M +2,954,348 New
PI
3
Putnam Investments
Massachusetts
$47.7M +$45.9M +2,871,068 New
Invesco
4
Invesco
Georgia
$47.5M +$45.6M +2,855,567 New
PAI
5
Palo Alto Investors
California
$47.4M +$45.5M +2,847,842 New
AG
6
Artal Group
Luxembourg
$43.9M +$42.1M +2,637,200 New
BFA
7
BlackRock Fund Advisors
California
$30.6M +$29.3M +1,837,072 New
Wellington Management Group
8
Wellington Management Group
Massachusetts
$27.7M +$26.6M +1,663,788 New
Citadel Advisors
9
Citadel Advisors
Florida
$27.3M +$26.3M +1,644,346 New
State Street
10
State Street
Massachusetts
$26.2M +$25.2M +1,577,779 New
BIT
11
BlackRock Institutional Trust
California
$25.2M +$24.2M +1,513,996 New
Fidelity Investments
12
Fidelity Investments
Massachusetts
$18.4M +$17.6M +1,104,910 New
SC
13
Samlyn Capital
New York
$16M +$15.4M +962,500 New
ClearBridge Investments
14
ClearBridge Investments
New York
$15.6M +$15M +937,728 New
Renaissance Technologies
15
Renaissance Technologies
New York
$15.4M +$14.8M +928,200 New
LOAMU
16
Lombard Odier Asset Management (USA)
New York
$15M +$14.4M +900,000 New
Millennium Management
17
Millennium Management
New York
$13.9M +$13.4M +837,186 New
SCA
18
SAC Capital Advisors
Connecticut
$13.4M +$12.9M +806,611 New
BC
19
Broadfin Capital
New York
$13.3M +$12.8M +800,000 New
Northern Trust
20
Northern Trust
Illinois
$12.3M +$11.9M +742,528 New
Deutsche Bank
21
Deutsche Bank
Germany
$12.2M +$11.8M +736,223 New
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$11.8M +$11.3M +707,133 New
Morgan Stanley
23
Morgan Stanley
New York
$11.7M +$11.2M +701,392 New
SGA
24
Sector Gamma AS
Norway
$11.4M +$10.9M +684,724 New
PWPCM
25
Perella Weinberg Partners Capital Management
New York
$9.78M +$9.4M +588,321 New
1
2 3 4 5

AUXL Hedge Fund Activity: Q2 2013 in Review

152 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q2 2013, worth a combined $880M.

Buyers outnumbered sellers: 152 funds opened new AUXL positions and 0 closed out — a net gain of 152 holders — while 0 added to existing stakes and 0 trimmed.

  • 152 institutional investors held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $880M of AUXILIUM PHARAMCEUTICALS INC stock for Q2 2013.
  • 152 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q2 2013 and 0 closed out, a net change of +152 holders.

Based on aggregated 13F filings for Q2 2013.